BRIEF published on 05/07/2025 at 14:41, 6 months 28 days ago Leadership Change at Carl Zeiss Meditec AG Carl Zeiss Meditec AG Leadership Change Maximilian Foerst Management Stability Greater China Market
PRESS RELEASE published on 05/07/2025 at 14:36, 6 months 28 days ago EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG Carl Zeiss Meditec AG announces change of President and CEO, Dr. Markus Weber, to be succeeded by Maximilian Foerst. Handover on May 31, 2025. Foerst appointed as new Executive Board member of Carl Zeiss AG Carl Zeiss Meditec AG President CEO Change Maximilian Foerst
BRIEF published on 04/15/2025 at 09:02, 7 months 20 days ago Carl Zeiss Meditec annonce de solides résultats au deuxième trimestre 2024/25 Croissance Des Revenus Marché Chinois Chirurgie Réfractive Résultats Du Deuxième Trimestre 2024/25 Augmentation De L'EBITA
BRIEF published on 04/15/2025 at 09:02, 7 months 20 days ago Carl Zeiss Meditec Reports Strong Q2 Earnings for 2024/25 Revenue Growth Refractive Surgery China Market Q2 2024/25 Earnings EBITA Increase
PRESS RELEASE published on 04/15/2025 at 08:57, 7 months 20 days ago EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25 Carl Zeiss Meditec AG achieves significant earnings increase in Q2 2024/25, with revenue of EUR 560 million and EBITA of EUR 78 million Revenue Growth Carl Zeiss Meditec AG Earnings Increase EBITA Q2 2024/25
BRIEF published on 02/27/2025 at 10:43, 9 months 5 days ago Le ZEISS VISUMAX 800 obtient l'approbation de la Chine Marché Chinois Approbation Réglementaire ZEISS VISUMAX 800 Laser Femtoseconde Amélioration Chirurgicale
BRIEF published on 02/27/2025 at 10:43, 9 months 5 days ago ZEISS VISUMAX 800 Gains China Approval Regulatory Approval China Market ZEISS VISUMAX 800 Femtosecond Laser Surgical Enhancement
PRESS RELEASE published on 02/27/2025 at 10:38, 9 months 5 days ago ZEISS VISUMAX 800 with SMILE pro software receives approval in China ZEISS VISUMAX 800 with SMILE pro software receives approval in China, providing faster treatment, flexibility, and workflow enhancements for refractive surgeons ZEISS VISUMAX 800 Femtosecond Laser SMILE Pro Software China Approval Refractive Surgeons
BRIEF published on 02/12/2025 at 07:03, 9 months 21 days ago Carl Zeiss Meditec annonce une croissance modeste de son chiffre d'affaires pour le premier trimestre 2024/25 Carl Zeiss Meditec Croissance Des Revenus Ophtalmologie Premier Trimestre 2024/25 Performances Mondiales
BRIEF published on 02/12/2025 at 07:03, 9 months 21 days ago Carl Zeiss Meditec Reports Modest Revenue Growth for Q1 2024/25 Revenue Growth Carl Zeiss Meditec Ophthalmology Q1 2024/25 Global Performance
Published on 12/05/2025 at 02:35, 6 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:05, 20 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 40 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 40 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 43 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 10 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 25 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
